Archive | Melanoma News

Governance of Research Melanoma

MRV is a multisite collaboration of clinical and non-clinical researchers, cohort participants and consumers.

Read the full story

Posted in Melanoma News, MRV Newsletters, Publications

Mass spec technology by Shimadzu unveils novel approach for immunotherapy success

Japan’s Shimadzu Corporation collaborated with Drs William Redmond and Yoshinobu Koguchi of the Providence Cancer Institute…

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Immune checkpoint inhibitors for cancer and venous thromboembolic events

BACKGROUND: Immune checkpoint inhibitors (ICIs) are widely used cancer treatments.

Read the full story

Posted in Melanoma News, Publications, Scientific Publications

Declining cancer incidence in the elderly: decreasing diagnostic intensity or biology?

BACKGROUND: Advanced age is a consistent risk factor for cancer, nonetheless cancer incidence typically declines after age 75-85 for most solid tumors.

Read the full story

Posted in Melanoma News, Publications, Scientific Publications